Animal Vaccine Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Animal Vaccine Market
1.1. Definition and Scope
1.1.1. Definition of Animal Vaccine
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Animal Vaccine Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Animal Vaccine Market By Product
1.2.3. Animal Vaccine Market By Animal Type
1.2.4. Animal Vaccine Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Animal Vaccine Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Animal Vaccine Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Animal Vaccine Market By Product
4.1. Introduction
4.2. Animal Vaccine Revenue By Product
4.2.1. Animal Vaccine Revenue (USD Million) and Forecast, By Product, 2018-2030
4.2.2. Attenuated Live Vaccines
4.2.2.1. Attenuated Live Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Inactivated Vaccines
4.2.3.1. Inactivated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.4. DNA Vaccines
4.2.4.1. DNA Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.5. Subunit Vaccines
4.2.5.1. Subunit Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.6. Recombinant Vaccines
4.2.6.1. Recombinant Vaccines Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Animal Vaccine Market By Animal Type
5.1. Introduction
5.2. Animal Vaccine Revenue By Animal Type
5.2.1. Animal Vaccine Revenue (USD Million) and Forecast, By Animal Type, 2018-2030
5.2.2. Poultry
5.2.2.1. Poultry Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Companion
5.2.3.1. Companion Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Aqua
5.2.4.1. Aqua Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Ruminants
5.2.5.1. Ruminants Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.6. Swine
5.2.6.1. Swine Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Animal Vaccine Market By Country
6.1. North America Animal Vaccine Market Overview
6.2. U.S.
6.2.1. U.S. Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
6.2.2. U.S. Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
6.3. Canada
6.3.1. Canada Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
6.3.2. Canada Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Animal Vaccine Market By Country
7.1. Europe Animal Vaccine Market Overview
7.2. U.K.
7.2.1. U.K. Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
7.2.2. U.K. Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
7.3. Germany
7.3.1. Germany Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
7.3.2. Germany Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
France
7.3.3. France Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
7.3.4. France Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
7.4. Spain
7.4.1. Spain Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
7.4.2. Spain Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
7.5. Rest of Europe
7.5.1. Rest of Europe Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
7.5.2. Rest of Europe Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
7.6. Europe PEST Analysis
CHAPTER 8. Asia Pacific Animal Vaccine Market By Country
8.1. Asia Pacific Animal Vaccine Market Overview
8.2. China
8.2.1. China Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
8.2.2. China Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
8.3. Japan
8.3.1. Japan Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
8.3.2. Japan Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
8.4. India
8.4.1. India Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
8.4.2. India Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
8.5. Australia
8.5.1. Australia Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
8.5.2. Australia Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
8.6. South Korea
8.6.1. South Korea Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
8.6.2. South Korea Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
8.7.2. Rest of Asia-Pacific Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Animal Vaccine Market By Country
9.1. Latin America Animal Vaccine Market Overview
9.2. Brazil
9.2.1. Brazil Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
9.2.2. Brazil Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
9.3. Mexico
9.3.1. Mexico Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
9.3.2. Mexico Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
9.4.2. Rest of Latin America Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Animal Vaccine Market By Country
10.1. Middle East & Africa Animal Vaccine Market Overview
10.2. GCC
10.2.1. GCC Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
10.2.2. GCC Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
10.3. South Africa
10.3.1. South Africa Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
10.3.2. South Africa Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Animal Vaccine Revenue (USD Million) and Forecast By Product, 2018-2030
10.4.2. Rest of Middle East & Africa Animal Vaccine Revenue (USD Million) and Forecast By Animal Type, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Animal Vaccine Market
11.1. Animal Vaccine Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Animal Vaccine Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. Company Profile
12.1. Merck & Co., Inc.
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Million), 2021
12.1.3.2. Merck & Co., Inc. 2021 Animal Vaccine Business Regional Distribution
12.1.4. Product/Service and Specification
12.1.5. Recent Developments & Business Strategy
12.2. Ceva
12.3. Boehringer Ingelheim International GmbH
12.4. Neogen Corporation
12.5. Intas Pharmaceuticals Ltd
12.6. Zoetis
12.7. Biogénesis Bagó
12.8. Pfizer Inc.
12.9. Elanco Animal Health
Frequently Asked Questions
What is the size of global animal vaccine market in 2021?
The estimated value of global animal vaccine market in 2021 was accounted to be USD 7,731 Million.
What is the CAGR of global animal vaccine market during forecast period of 2022 to 2030?
The projected CAGR animal vaccine market during the analysis period of 2022 to 2030 is 7.5%.
Which are the key players operating in the market?
The prominent players of the global animal vaccine market are Merck & Co., Inc., Ceva, Boehringer Ingelheim International GmbH, Neogen Corporation, Intas Pharmaceuticals Ltd, Zoetis, Biogénesis Bagó, Pfizer Inc., and Elanco Animal Health.
Which region held the dominating position in the global animal vaccine market?
North America held the dominating animal vaccine during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for animal vaccine during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global animal vaccine market?
Increase in the frequency of animal disease, and rise in animal health spending drives the growth of global animal vaccine market.
By animal type segment, which sub-segment held the maximum share?
Based on animal type, poultry segment is expected to hold the maximum share of the animal vaccine market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
